000 01579 a2200409 4500
005 20250516231301.0
264 0 _c20150515
008 201505s 0 0 eng d
022 _a1538-0688
024 7 _a10.1188/14.ONF.551-553
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHeld-Warmkessel, Jeanne
245 0 0 _aGemcitabine-associated thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.
_h[electronic resource]
260 _bOncology nursing forum
_cSep 2014
300 _a551-3 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article
650 0 4 _aAdenocarcinoma
_xcomplications
650 0 4 _aAntibodies, Monoclonal, Murine-Derived
_xtherapeutic use
650 0 4 _aAntihypertensive Agents
_xadministration & dosage
650 0 4 _aAntimetabolites, Antineoplastic
_xadverse effects
650 0 4 _aBlood Component Transfusion
650 0 4 _aDeoxycytidine
_xadverse effects
650 0 4 _aDisease Management
650 0 4 _aHemolytic-Uremic Syndrome
_xchemically induced
650 0 4 _aHumans
650 0 4 _aHypertension
_xcomplications
650 0 4 _aKidney Failure, Chronic
_xchemically induced
650 0 4 _aNursing Assessment
650 0 4 _aPancreatic Neoplasms
_xcomplications
650 0 4 _aPlasmapheresis
650 0 4 _aPurpura, Thrombotic Thrombocytopenic
_xchemically induced
650 0 4 _aRenal Dialysis
650 0 4 _aRituximab
650 0 4 _aGemcitabine
773 0 _tOncology nursing forum
_gvol. 41
_gno. 5
_gp. 551-3
856 4 0 _uhttps://doi.org/10.1188/14.ONF.551-553
_zAvailable from publisher's website
999 _c24131769
_d24131769